Background Artemether–lumefantrine (AL) and artesunate–amodiaquine are first-line
treatment for uncomplicated malaria in many endemic countries, including Mali …

Background Sub-Saharan Africa has the highest burden of malaria in the world. Artemisinin-
based combination therapies (ACTs) have been the cornerstone in the efforts to reduce the …

Background Artemether–lumefantrine (AL) is the recommended first-line artemisinin-based
combination therapy (ACT) for the treatment of uncomplicated falciparum malaria in most of …

Artemisinin-based combination therapies (ACT) are now being adopted as first-line
treatments against uncomplicated malaria in sub-Saharan Africa. Between December 2009 …

Background The choice of appropriate artemisinin-based combination therapy depends on
several factors (cost, efficacy, safety, reinfection rate and simplicity of administration). To …

We conducted an open, randomized clinical trial of oral dihydroartemisinin-piperaquine (DP)
versus artesunate-mefloquine (AM) in 300 patients in Laos with uncomplicated Plasmodium …

Background Since 2006, the artemisinin-based combination therapy (ACT) are
recommended to treat uncomplicated malaria including non Plasmodium falciparum malaria …

Background Artemisinin-based combination therapy (ACT) has been the recommended first-
line treatment for uncomplicated malaria in Mozambique since 2006, with artemether …

Background Artesunate and amodiaquine (AS&AQ) is at present the world's second most
widely used artemisinin-based combination therapy (ACT). It was necessary to evaluate the …

Background Malaria remains a major public health problem, affecting mainly low-and middle-
income countries. The management of this parasitic disease is challenged by ever …